Talent Biomedical received registration certificates from Turkish Ministry of Health for Automatic IHC stainer and IHC detection system on August, 2024. It’s a big milestone which will greatly help Talent Biomedical to develop Turkish IHC market. Prior to this, these two products also received NMPA approval in 2018 and CE certification in 2023. Talent Biomedical will continue to research and develop pathological products with high performance, to serve the global market needs in pathological field. About Talent Biomedical In 2017, Talent Biomedical was founded by Dr. Guo who among the first few pioneers in developing polymer IHC detection systems, had been engaging in pathological diagnosis research for more than 30 years. Through 7 years of development, Talent Biomedical has world class IHC polymer detection system and “high throughput automatic stainer (whole staining process of 144 slides only takes around 3 hours)”, in addition, Talent Biomedical developed more than 300 primary antibodies, as well as ISH products, suitable for clinical IHC applications. For more information, please visit www.talentdiagnostics.com.

On 11 December 2023, Talent Biomedical received CE certification for Automatic IHC stainer and related reagents. It will greatly help Talent Biomedical to access to markets overseas.  As for in vitro diagnostic products, getting CE certification proves that the products have been rigorously audited and assessed to compliance with the European regulations of technical, safety and performance requirements, as well as other requirements for in vitro diagnostic products. Talent Biomedical will continue to lead with technological innovation, fully leveraging the advantages of sound quality system, continue to focus on the field of IHC products, develop innovative and compliant diagnostic tools based on clinical needs to serve patients worldwide.   About Talent Biomedical In 2017, Talent Biomedical was founded by Dr. Guo who among the first few pioneers in developing polymer IHC detection systems, had been engaging in pathological diagnosis research for more than 30 years. Through 7 years of development, Talent Biomedical has world class IHC polymer detection system and “high throughput automatic stainer (whole staining process of 144 slides only takes around 3.5 hours)”, in addition, Talent Biomedical developed more than 300 primary antibodies, as well as ISH products, suitable for clinical IHC applications. For more information, please visit www.talentdiagnostics.com.

Le 10 mai 2022, Talent Biomedical était fier d'annoncer que nous avions terminé le processus de certification ISO 13485. ISO 13485 est un ensemble de normes qui définissent et contrôlent le système de gestion de la qualité de l'entreprise, spécifiquement pour la fabrication de dispositifs médicaux et autres produits de santé. -Produits connexes. Bien qu'il ne s'agisse pas d'une licence spécifique pour un dispositif médical, il s'agit d'une démonstration claire de la responsabilité et de la conformité d'un fournisseur aux meilleures pratiques de l'industrie lors de la fabrication de composants essentiels à la protection de la santé humaine.